Here are five health companies Intel is investing in:
- Intel Capital recently led a $20 million funding round for MDI Health, a medication management company using artificial intelligence.
- In August 2022, Intel Capital joined in a $320 million series D financing round for virtual care and digital medicine company Biofourmis.
- In January 2022, the company joined in a $15 million series A financing round for VeriSIM Life, a company that uses artificial intelligence to predict clinical outcomes.
- Intel Capital invested in health information services and devices company Exo in August 2021.
- Intel Capital joined in a $105 million series B financing round for gene therapy company Senti Bio in January 2021.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.